INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 46m ago
HOUSE PTR5m ago
SEC 13F5m ago
ROBINHOOD CHAIN5m ago
LT
Corporate insider

Leggett Thomas

Chief Financial OfficerCIK 0001774690

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 5
Max Insider Score40
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$1,215
37 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Stoke Therapeutics, Inc.Chief Financial Officer · Mar 19, 2026
39
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL
$68K
2,173 sh
Mar 18, 2026
Mar 19, 2026
traded Mar 18, 2026
+1d
SEC FORM 4

Evidence

40
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$31K
922 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC FORM 4

Evidence

40
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$42K
1,274 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC FORM 4

Evidence

32
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$5,468
172 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence